Aethlon Medical, Inc. (AEMD)

Aethlon Medical Income Statement

Financials in millions USD. Fiscal year is April - March.

Year	2023	2022	2021	2020	2019
Revenue	0	0.57	0.29	0.66	0.65
Revenue Growth (YoY)	-	95.21%	-55.37%	1.37%	183.15%
Gross Profit	0	0.57	0.29	0.66	0.65
Selling, General & Admin	3.9	4.48	3.46	2.46	1.55
Other Operating Expenses	8.73	7.99	7.26	6.09	5.03
Operating Expenses	12.64	12.47	10.72	8.55	6.58
Operating Income	-12.64	-11.9	-10.42	-7.89	-5.93
Interest Expense / Income	0	0	0	0	0.05
Other Expense / Income	-0.43	0.13	-0	-0	0.39
Pretax Income	-12.21	-12.03	-10.42	-7.89	-6.37
Net Income	-12.21	-12.03	-10.42	-7.89	-6.37
Shares Outstanding (Basic)	3	2	1	1	0
Shares Outstanding (Diluted)	3	2	1	1	0
Shares Change	22.35%	39.17%	22.05%	254.07%	182.61%
EPS (Basic)	-4.86	-5.86	-7.10	-6.50	-18.70
EPS (Diluted)	-4.86	-5.86	-7.10	-6.50	-18.70
Free Cash Flow	-10.38	-11.45	-10.12	-6.82	-5.35
Free Cash Flow Per Share	-4.13	-5.57	-6.86	-5.64	-15.66
Gross Margin	-	100.00%	100.00%	100.00%	100.00%
Operating Margin	-	-2072.05%	-3542.53%	-1197.31%	-912.04%
Profit Margin	-	-2094.89%	-3540.90%	-1196.58%	-980.33%
Free Cash Flow Margin	-	-1993.62%	-3439.01%	-1035.47%	-822.73%
EBITDA	-11.85	-11.76	-10.26	-7.85	-6.29
EBITDA Margin	-	-2048.69%	-3488.48%	-1190.90%	-967.93%
Depreciation & Amortization	0.36	0.27	0.15	0.04	0.03
EBIT	-12.21	-12.03	-10.42	-7.89	-6.32
EBIT Margin	-	-2094.89%	-3540.90%	-1196.58%	-971.98%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).